Morgan Stanley (NYSE: MCD) Form 144: Erlinger 10b5-1 sales disclosed
Rhea-AI Filing Summary
Morgan Stanley Smith Barney LLC submitted a Form 144 notice reporting proposed sales of Common Stock tied to 10b5-1 arrangements for Joseph Erlinger. The filing lists multiple recent 10b5-1 sales: 2,626 shares on 03/10/2026 ($862,220.84), 333 shares on 02/23/2026 ($110,033.19), and earlier 10b5-1 sales on 02/10/2026 and 01/12/2026 with shares listed as 2,626 on each date and corresponding dollar amounts. The filing identifies Performance Restricted Stock Units dated 02/13/2026 and shows the broker/dealer as Morgan Stanley Smith Barney LLC in New York.
Positive
- None.
Negative
- None.
Insights
Form 144 records routine, pre-arranged 10b5-1 sales by Joseph Erlinger.
The notice lists specific 10b5-1 dispositions: 2,626 shares (03/10/2026), 333 shares (02/23/2026), and matching 2,626 entries on 02/10/2026 and 01/12/2026 with dollar amounts shown. These are reported sales rather than new grants.
Cash‑flow treatment and whether other shares remain subject to restriction are not detailed in the excerpt; subsequent filings will show final settlement and any remaining holdings.
FAQ
What does the Form 144 for MCD show about Joseph Erlinger?
Which broker handled the reported transactions in the Form 144?
Were the sales described in the Form 144 executed under a trading plan?
Does the Form 144 disclose proceeds from the listed sales?